Nicolas Widmer

Nicolas Widmer

Université de Lausanne - Lausanne / Switzerland
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 1082533
Universität Lausanne
person_outline Nicolas Widmer's MOST POPULAR ARTICLES
1-) Towards a new combination therapy for tuberculosis with next generation benzothiazinonesV Makarov, B Lechartier, M Zhang, J Neres, AM van der Sar, SA Raadsen, ...EMBO molecular medicine 6 (3), 372-383, 20143252014
2-) Review of therapeutic drug monitoring of anticancer drugs part two–targeted therapiesN Widmer, C Bardin, E Chatelut, A Paci, J Beijnen, D Levêque, G Veal, ...European journal of cancer 50 (12), 2020-2036, 20143002014
3-) Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinibA Haouala, N Widmer, MA Duchosal, M Montemurro, T Buclin, ...Blood, The Journal of the American Society of Hematology 117 (8), e75-e87, 20112492011
4-) Review of therapeutic drug monitoring of anticancer drugs part 1–cytotoxicsA Paci, G Veal, C Bardin, D Levêque, N Widmer, J Beijnen, A Astier, ...European journal of cancer 50 (12), 2010-2019, 20143012014
5-) Therapeutic drug monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometryA Haouala, B Zanolari, B Rochat, M Montemurro, K Zaman, MA Duchosal, ...Journal of Chromatography B 877 (22), 1982-1996, 20092402009